News
President Trump claimed his “most favored nation” executive order could cause U.S. drug prices to “drop like a rock” in a ...
Your commitment strengthens our ability to report fearlessly on the topics that matter most to you.
Nation's leading advisory body on issues of science and technology is "preparing for a fairly radical downsizing." ...
A Merus drug, combined with Keytruda, shows preliminary survival gains in newly diagnosed metastatic head and neck cancer ...
The notice came shortly after an advisory panel meeting at which members debated the pros and cons of asking manufacturers to ...
From new hires to departures, promotions and transfers, here are the latest comings and goings in the pharmaceutical industry ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud.
In a letter sent Tuesday, Sen. Lisa Blunt Rochester (D-Del.) demanded that health secretary Robert Kennedy clarify whether ...
In its flagship journal, the CDC keeps publishing papers after firing scientists who made the research possible.
People often think that they will be perfectly fine with just one kidney. But there are long-term health consequences, and ...
The MAHA commission's assessment of children's health mirrored RFK Jr.'s familiar targets. The question now is what remedies ...
FDA chief pushes back on senators’ criticism, says Covid booster trials should take ‘roughly a year’
The hearing was supposed to focus on the Trump administration’s 2026 budget request, but instead covered a wide range of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results